Allison Bratzel
Stock Analyst at Piper Sandler
(5)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IONS Ionis Pharmaceutical... | Maintains: Overweight | 62 65 | 42.77 | 51.98% | 2 | Aug 22, 2025 | |
ABVX Abivax | Maintains: Overweight | 70 112 | 77 | 45.45% | 1 | Jul 29, 2025 | |
REPL Replimune Group | Maintains: Overweight | 14 22 | 5.69 | 286.64% | 2 | Jun 2, 2025 | |
TYRA Tyra Biosciences | Assumes: Overweight | 33 | 12.08 | 173.18% | 1 | May 21, 2025 | |
RARE Ultragenyx Pharmaceu... | Maintains: Overweight | 140 115 | 29.86 | 285.13% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 4 6 | 3.21 | 86.92% | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 23 | 4 | 475% | 1 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 26 | 4.15 | 526.51% | 1 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 620 725 | 662.61 | 9.42% | 13 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 22 | 17.95 | 22.56% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 23 | 41.86 | -45.05% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 42 | 35.65 | 17.81% | 3 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 22 | 11.93 | 84.41% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 4 | 1.56 | 156.41% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 8 20 | 5.92 | 237.84% | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 20 | 4.4 | 354.55% | 1 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 25 | 16.87 | 48.19% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 100 | 85.49 | 16.97% | 2 | Feb 8, 2023 |